During the past decade, Aou San Luigi Gonzaga conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 46 clinical trials were completed, i.e. on average, 43.4% percent of trials that started reached the finish line to date. In the past 5 years, 64 clinical trials started and 27 clinical trials were completed. i.e. 42.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aou San Luigi Gonzaga" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 19 trials, followed by "Celgene" with 14 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 93 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aou San Luigi Gonzaga" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 4 trials as a collaborator, "Astellas Pharma Inc" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Arcispedale Santa Maria Nuova-IRCCS" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Aou San Luigi Gonzaga" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Leukemia" (7 trials), "Non-Small Cell Lung Cancer" (7 trials), "Acute Myeloid Leukemia" (6 trials) and "Chronic Myeloid Leukemia" (5 trials). Many other conditions were trialed in "Aou San Luigi Gonzaga" in a lesser frequency.

Most popular intervention types in "Aou San Luigi Gonzaga" are "Drug" (129 trials), "Other" (16 trials), "Procedure" (7 trials), "Biological" (6 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Cisplatin" (8 trials), "Pemetrexed" (8 trials), "Docetaxel" (7 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Aou San Luigi Gonzaga" are 152 trials for "All" genders, 8 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aou San Luigi Gonzaga". undefined are not yet recruiting, 45 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Aou San Luigi Gonzaga, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Aou San Luigi Gonzaga, 4 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".

Aou San Luigi Gonzaga has several departments that took part in Clinical trials: "A.O. UNIVERSITARIA S. LUIGI GONZAGA; Oncologia Medica" - 4 trials, "Medicina Interna II Divisione di Ematologia, Ospedale S. Luigi Gonzaga" - 4 trials, "Azienda Sanitaria Ospedaliera S Luigi Gonzaga; SSD Oncologia Polomonare (II PAD. IV PIANO)" - 2 trials, "Ospedale San Luigi Gonzaga - S.C.D.O. Cardiologia" - 3 trials, "Azienda Sanitaria Ospedaliera S. Luigi Gonzaga; Centro Regionale Sclerosi Multipla - Neurologia II" - 2 trials, "Azienda Sanitaria Ospedaliera S Luigi Gonzaga; S.C.D.U. di Oncologia Toracica" - 2 trials